As the U.S. broke its single-day COVID case record with nearly 500,000 new confirmed cases on Wednesday, scientists revealed a bit of good news in the fight against the highly contagious Omicron variant
. A new study conducted in South Africa has found that a booster shot of the Johnson & Johnson vaccine protects against severe illness from the powerful strain, perhaps even better than the Pfizer-BioNTech vaccine. As reported bythe study juxtaposed over 69,000 J&J vaccinated health care workers against the same amount of unvaccinated participants.
The results concluded that two doses of the vaccine reduced hospitalization rates by 85 percent. In a corresponding study, the Pfizer vaccine reduced hospitalizations by 70 percent. The Centers for Disease Control and Prevention has said the J&J shot can on rare occasion cause blood clots, though the treatment is in fact approved by the U.S. Food and Drug Administration.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Studies indicate J&J Covid-19 vaccine booster protects people against severe illness from Omicron variantTwo reports released Thursday show that people who get booster doses of Johnson & Johnson's Janssen vaccine are well protected against severe disease and hospitalization from the Omicron variant of coronavirus, the company said.
Baca lebih lajut »
J&J vaccine booster protects against severe omicron illness hospitalization, company saysThe studies have not yet been peer-reviewed and were released by J&J prior being printed in a peer-reviewed journal.
Baca lebih lajut »
J&J vaccine, booster 85% effective in preventing severe omicron infection, study saysOn Thursday, Johnson & Johnson released new data showing that its COVID-19 vaccine and booster shot offers significant protection against hospitalization caused by the omicron variant.
Baca lebih lajut »
J&J's COVID-19 vaccine booster was 85% effective against hospitalization, in South Africa studyJohnson & Johnson undefined said Thursday that a South African Phase 3 study showed that its a booster shot of its COVID-19 vaccine was 85% effective in...
Baca lebih lajut »
Study: Omicron variant may help to ward off more severe deltaResearchers say omicron may be able to give protection against the more severe delta variant
Baca lebih lajut »
J&J booster offers strong protection against omicron, study showsJohnson & Johnson's booster provides strong protection against the omicron variant of Covid-19, according to a trial of healthcare workers in South Africa.
Baca lebih lajut »